To the contrary, the long-term induction of hyperactive Nrf2 is also reconsidered as a potent oncogenic driver with several hallmarks of cancer; this is based on its bona fide tumor-promoting effects and also resistance to chemotherapy [30,31]. The gene discussed is NFE2L2; the disease is cancer.